Egerton Capital (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-124,045	Closed	-$57.7M	–	37
2024 Q3	$57.7M	Buy	+124,045	New	+$57.7M	0.58%	26